Yang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yang Wang has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Guocheng Du
Science Center for Future Foods Jiangnan University Wuxi China
11 shared publicationsJian Chen
Science Center for Future Foods Jiangnan University Wuxi China
10 shared publications- Zhen Kang
The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China
10 shared publications Jianghua Li
Science Center for Future Foods Jiangnan University Wuxi China
5 shared publicationsYulong Xiang
Science Center for Future Foods Jiangnan University Wuxi China
4 shared publicationsZhen Kang
The Science Center for Future Foods, Jiangnan University, Wuxi, 214122, China
4 shared publications
Latest Publications
- 23 April 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (7) , 1799-1813
Uncovering N‐Glycosylation‐Mediated Allosteric Activation Coupled With Stability Design Enabling High‐Yield Human Enterokinase Production
Glycosylation, a prevalent post‐translational modification, regulates numerous cellular processes and modulates protein activity. Proteinases are the most widely researched enzymes, many of which were glycosylated in eukaryotes. Serine protease enteropeptidase used in pharmaceuticals and biotechnology industry, due to its specifical recognition and clean cleaves of the D 4 K polypeptide sequence, are N‐glycosylated at four sites. In this study, we focused on glycosylation and deglycosylation engineering of human light‐chain enteropeptidase (HLEK) to obtain more efficient mutants. By creating a series of site‐directed deglycosylation mutants, we found that glycosylation sites Asn103 and Asn165 that are remote from the catalytic center, significantly enhanced HLEK's enzymatic activity. Molecular dynamics simulations combined with Protein Residue Dynamical Network (PRDN) analysis revealed that glycosylation shortens signal‐transmission paths across the residue network, providing a mechanistic basis for the observed k cat enhancement. Specifically, presence of N‐glycosylation shortens the residues signal‐transmission paths, thereby increasing k cat . As the fully deglycosylated HLEK (N64Q/N103Q/N125Q/N165Q), suffered from low expression, we performed ΔΔ G guided design, the generated mutants demonstrated 76.5‐fold increase in expression levels but 9.7‐fold decrease in catalytic activities. Re‐introduction of N‐gycosylation at 103 and 165 to the designed mutant restored allosteric activation and yielded a substantially improved total enzyme output. In fed‐batch fermentation, this HLEK mutant reached a total enzyme activity of 5.86 × 10 6 ± 2.52 × 10 5 U L −1 (358 mg/L, four times the highest level previously reported). Our results show that distal N‐glycosylation can allosterically accelerate catalysis via remodeling of residue interaction networks, and that combining N‐glycosylation‐guided mechanistic insights with stability engineering offers a robust route to high‐yield, high‐activity protease production.
- 23 April 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (7) , 1799-1813
Uncovering N‐Glycosylation‐Mediated Allosteric Activation Coupled With Stability Design Enabling High‐Yield Human Enterokinase Production
Glycosylation, a prevalent post‐translational modification, regulates numerous cellular processes and modulates protein activity. Proteinases are the most widely researched enzymes, many of which were glycosylated in eukaryotes. Serine protease enteropeptidase used in pharmaceuticals and biotechnology industry, due to its specifical recognition and clean cleaves of the D 4 K polypeptide sequence, are N‐glycosylated at four sites. In this study, we focused on glycosylation and deglycosylation engineering of human light‐chain enteropeptidase (HLEK) to obtain more efficient mutants. By creating a series of site‐directed deglycosylation mutants, we found that glycosylation sites Asn103 and Asn165 that are remote from the catalytic center, significantly enhanced HLEK's enzymatic activity. Molecular dynamics simulations combined with Protein Residue Dynamical Network (PRDN) analysis revealed that glycosylation shortens signal‐transmission paths across the residue network, providing a mechanistic basis for the observed k cat enhancement. Specifically, presence of N‐glycosylation shortens the residues signal‐transmission paths, thereby increasing k cat . As the fully deglycosylated HLEK (N64Q/N103Q/N125Q/N165Q), suffered from low expression, we performed ΔΔ G guided design, the generated mutants demonstrated 76.5‐fold increase in expression levels but 9.7‐fold decrease in catalytic activities. Re‐introduction of N‐gycosylation at 103 and 165 to the designed mutant restored allosteric activation and yielded a substantially improved total enzyme output. In fed‐batch fermentation, this HLEK mutant reached a total enzyme activity of 5.86 × 10 6 ± 2.52 × 10 5 U L −1 (358 mg/L, four times the highest level previously reported). Our results show that distal N‐glycosylation can allosterically accelerate catalysis via remodeling of residue interaction networks, and that combining N‐glycosylation‐guided mechanistic insights with stability engineering offers a robust route to high‐yield, high‐activity protease production.
- 27 March 2026
- Published by Springer Nature in Systems Microbiology and Biomanufacturing
- Vol. 6 (2) , 53
A lightweight toolkit of synthetic promoters and regulatory sRNAs for gene expression regulation in industrial Streptococcus
- 27 March 2026
- Published by Springer Nature in Systems Microbiology and Biomanufacturing
- Vol. 6 (2) , 53
A lightweight toolkit of synthetic promoters and regulatory sRNAs for gene expression regulation in industrial Streptococcus
- Open Access
- 1 June 2024
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 9 (2) , 223-233
Regulatory RNAs in Bacillus subtilis: A review on regulatory mechanism and applications in synthetic biology
Bacteria exhibit a rich repertoire of RNA molecules that intricately regulate gene expression at multiple hierarchical levels, including small RNAs (sRNAs), riboswitches, and antisense RNAs. Notably, the majority of these regulatory RNAs lack or have limited protein-coding capacity but play pivotal roles in orchestrating gene expression by modulating transcription, post-transcription or translation processes. Leveraging and redesigning these regulatory RNA elements have emerged as pivotal strategies in the domains of metabolic engineering and synthetic biology. While previous investigations predominantly focused on delineating the roles of regulatory RNA in Gram-negative bacterial models such as Escherichia coli and Salmonella enterica, this review aims to summarize the mechanisms and functionalities of endogenous regulatory RNAs inherent to typical Gram-positive bacteria, notably Bacillus subtilis. Furthermore, we explore the engineering and practical applications of these regulatory RNA elements in the arena of synthetic biology, employing B. subtilis as a foundational chassis.
- 1 June 2024
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 9 (2) , 223-233
Open AccessRegulatory RNAs in Bacillus subtilis: A review on regulatory mechanism and applications in synthetic biology
Bacteria exhibit a rich repertoire of RNA molecules that intricately regulate gene expression at multiple hierarchical levels, including small RNAs (sRNAs), riboswitches, and antisense RNAs. Notably, the majority of these regulatory RNAs lack or have limited protein-coding capacity but play pivotal roles in orchestrating gene expression by modulating transcription, post-transcription or translation processes. Leveraging and redesigning these regulatory RNA elements have emerged as pivotal strategies in the domains of metabolic engineering and synthetic biology. While previous investigations predominantly focused on delineating the roles of regulatory RNA in Gram-negative bacterial models such as Escherichia coli and Salmonella enterica, this review aims to summarize the mechanisms and functionalities of endogenous regulatory RNAs inherent to typical Gram-positive bacteria, notably Bacillus subtilis. Furthermore, we explore the engineering and practical applications of these regulatory RNA elements in the arena of synthetic biology, employing B. subtilis as a foundational chassis.
- 26 May 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (5) , e2400098
High‐activity recombinant human carboxypeptidase B expression in Pichia pastoris through rational protein engineering and enhancing secretion from the Golgi apparatus to the plasma membrane
Human carboxypeptidase B1 (hCPB1) is vital for recombinant insulin production, holding substantial value in the pharmaceutical industry. Current challenges include limited hCPB1 enzyme activity. In this study, recombinant hCPB1 efficient expression in Pichia pastoris was achieved. To enhance hCPB1 secretion, we conducted signal peptides screening and deleted the Vps10 sortilin domain, reducing vacuolar mis‐sorting. Overexpression of Sec4p increased the fusion of secretory vesicles with the plasma membrane and improved hCPB1 secretion by 20%. Rational protein engineering generated twenty‐two single‐mutation mutants and identified the A178L mutation resulted in a 30% increase in hCPB1 specific activity. However, all combinational mutations that increased specific activities decreased protein expression levels. Therefore, computer‐aided global protein design with PROSS was employed for the aim of improving specific activities and preserving good protein expression. Among the six designed mutants, hCPB1‐P6 showed a remarkable 114% increase in the catalytic rate constant (kcat), a 137% decrease in the Michaelis constant (Km), and a 490% increase in catalytic efficiency. Most mutations occurred on the surface of hCPB1‐P6, with eight sites mutated to proline. In a 5 L fermenter, hCPB1‐P6 was produced by the secretion‐enhanced P. pastoris chassis to 199.6 ± 20 mg L−1 with a specific activity of 96 ± 0.32 U mg−1, resulting in a total enzyme activity of 19137 ± 1131 U L−1, demonstrating significant potential for industrial applications.
- 26 May 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (5) , e2400098
High‐activity recombinant human carboxypeptidase B expression in Pichia pastoris through rational protein engineering and enhancing secretion from the Golgi apparatus to the plasma membrane
Human carboxypeptidase B1 (hCPB1) is vital for recombinant insulin production, holding substantial value in the pharmaceutical industry. Current challenges include limited hCPB1 enzyme activity. In this study, recombinant hCPB1 efficient expression in Pichia pastoris was achieved. To enhance hCPB1 secretion, we conducted signal peptides screening and deleted the Vps10 sortilin domain, reducing vacuolar mis‐sorting. Overexpression of Sec4p increased the fusion of secretory vesicles with the plasma membrane and improved hCPB1 secretion by 20%. Rational protein engineering generated twenty‐two single‐mutation mutants and identified the A178L mutation resulted in a 30% increase in hCPB1 specific activity. However, all combinational mutations that increased specific activities decreased protein expression levels. Therefore, computer‐aided global protein design with PROSS was employed for the aim of improving specific activities and preserving good protein expression. Among the six designed mutants, hCPB1‐P6 showed a remarkable 114% increase in the catalytic rate constant (kcat), a 137% decrease in the Michaelis constant (Km), and a 490% increase in catalytic efficiency. Most mutations occurred on the surface of hCPB1‐P6, with eight sites mutated to proline. In a 5 L fermenter, hCPB1‐P6 was produced by the secretion‐enhanced P. pastoris chassis to 199.6 ± 20 mg L−1 with a specific activity of 96 ± 0.32 U mg−1, resulting in a total enzyme activity of 19137 ± 1131 U L−1, demonstrating significant potential for industrial applications.
- 30 March 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (14) , 8006-8017
Construction of 5-Aminolevulinic Acid Microbial Cell Factories through Identification of Novel Synthases and Metabolic Pathway Screens and Transporters
5-Aminolevulinic acid (5-ALA) plays a pivotal role in the biosynthesis of heme and chlorophyll and has garnered great attention for its agricultural applications. This study explores the multifaceted construction of 5-ALA microbial cell factories. Evolutionary analysis-guided screening identified a novel 5-ALA synthase from Sphingobium amiense as the best synthase. An sRNA library facilitated global gene screening that demonstrated that trpC and ilvA repression enhanced 5-ALA production by 74.3% and 102%, respectively. Subsequently, efflux of 5-ALA by the transporter Gdx increased 5-ALA biosynthesis by 25.7%. To mitigate oxidative toxicity, DNA-binding proteins from starved cells were employed, enhancing cell density and 5-ALA titer by 21.1 and 4.1%, respectively. Combining these strategies resulted in an Escherichia coli strain that produced 5-ALA to 1.51 g·L–1 in shake flask experiments and 6.19 g·L–1 through fed-batch fermentation. This study broadens the repertoire of available 5-ALA synthases and transporters and provides a new platform for optimizing 5-ALA bioproduction.
- 30 March 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (14) , 8006-8017
Construction of 5-Aminolevulinic Acid Microbial Cell Factories through Identification of Novel Synthases and Metabolic Pathway Screens and Transporters
5-Aminolevulinic acid (5-ALA) plays a pivotal role in the biosynthesis of heme and chlorophyll and has garnered great attention for its agricultural applications. This study explores the multifaceted construction of 5-ALA microbial cell factories. Evolutionary analysis-guided screening identified a novel 5-ALA synthase from Sphingobium amiense as the best synthase. An sRNA library facilitated global gene screening that demonstrated that trpC and ilvA repression enhanced 5-ALA production by 74.3% and 102%, respectively. Subsequently, efflux of 5-ALA by the transporter Gdx increased 5-ALA biosynthesis by 25.7%. To mitigate oxidative toxicity, DNA-binding proteins from starved cells were employed, enhancing cell density and 5-ALA titer by 21.1 and 4.1%, respectively. Combining these strategies resulted in an Escherichia coli strain that produced 5-ALA to 1.51 g·L–1 in shake flask experiments and 6.19 g·L–1 through fed-batch fermentation. This study broadens the repertoire of available 5-ALA synthases and transporters and provides a new platform for optimizing 5-ALA bioproduction.
- Open Access
- 10 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Engineering sulfonate group donor regeneration systems to boost biosynthesis of sulfated compounds
Sulfonation as one of the most important modification reactions in nature is essential for many biological macromolecules to function. Development of green sulfonate group donor regeneration systems to efficiently sulfonate compounds of interest is always attractive. Here, we design and engineer two different sulfonate group donor regeneration systems to boost the biosynthesis of sulfated compounds. First, we assemble three modules to construct a 3'-phosphoadenosine-5'-phosphosulfate (PAPS) regeneration system and demonstrate its applicability for living cells. After discovering adenosine 5’-phosphosulfate (APS) as another active sulfonate group donor, we engineer a more simplified APS regeneration system that couples specific sulfotransferase. Next, we develop a rapid indicating system for characterizing the activity of APS-mediated sulfotransferase to rapidly screen sulfotransferase variants with increased activity towards APS. Eventually, the active sulfonate group equivalent values of the APS regeneration systems towards trehalose and p-coumaric acid reach 3.26 and 4.03, respectively. The present PAPS and APS regeneration systems are environmentally friendly and applicable for scaling up the biomanufacturing of sulfated products.
- 10 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Open AccessEngineering sulfonate group donor regeneration systems to boost biosynthesis of sulfated compounds
Sulfonation as one of the most important modification reactions in nature is essential for many biological macromolecules to function. Development of green sulfonate group donor regeneration systems to efficiently sulfonate compounds of interest is always attractive. Here, we design and engineer two different sulfonate group donor regeneration systems to boost the biosynthesis of sulfated compounds. First, we assemble three modules to construct a 3'-phosphoadenosine-5'-phosphosulfate (PAPS) regeneration system and demonstrate its applicability for living cells. After discovering adenosine 5’-phosphosulfate (APS) as another active sulfonate group donor, we engineer a more simplified APS regeneration system that couples specific sulfotransferase. Next, we develop a rapid indicating system for characterizing the activity of APS-mediated sulfotransferase to rapidly screen sulfotransferase variants with increased activity towards APS. Eventually, the active sulfonate group equivalent values of the APS regeneration systems towards trehalose and p-coumaric acid reach 3.26 and 4.03, respectively. The present PAPS and APS regeneration systems are environmentally friendly and applicable for scaling up the biomanufacturing of sulfated products.
- 1 September 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 253 (Pt 1) , 126551
Advances and challenges in biotechnological production of chondroitin sulfate and its oligosaccharides
- 1 September 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 253 (Pt 1) , 126551
Advances and challenges in biotechnological production of chondroitin sulfate and its oligosaccharides
- Open Access
- 6 April 2023
- Published by Elsevier in Engineering Microbiology
- Vol. 3 (4) , 100086
Yeast surface display of leech hyaluronidase for the industrial production of hyaluronic acid oligosaccharides
- 6 April 2023
- Published by Elsevier in Engineering Microbiology
- Vol. 3 (4) , 100086
Open AccessYeast surface display of leech hyaluronidase for the industrial production of hyaluronic acid oligosaccharides
- Open Access
- 19 June 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Eliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum
Hyaluronan is widely used in cosmetics and pharmaceutics. Development of robust and safe cell factories and cultivation approaches to efficiently produce hyaluronan is of many interests. Here, we describe the metabolic engineering of Corynebacterium glutamicum and application of a fermentation strategy to manufacture hyaluronan with different molecular weights. C. glutamicum is engineered by combinatorial overexpression of type I hyaluronan synthase, enzymes of intermediate metabolic pathways and attenuation of extracellular polysaccharide biosynthesis. The engineered strain produces 34.2 g L−1 hyaluronan in fed-batch cultures. We find secreted hyaluronan encapsulates C. glutamicum, changes its cell morphology and inhibits metabolism. Disruption of the encapsulation with leech hyaluronidase restores metabolism and leads to hyper hyaluronan productions of 74.1 g L−1. Meanwhile, the molecular weight of hyaluronan is also highly tunable. These results demonstrate combinatorial optimization of cell factories and the extracellular environment is efficacious and likely applicable for the production of other biopolymers.
- 19 June 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Open AccessEliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum
Hyaluronan is widely used in cosmetics and pharmaceutics. Development of robust and safe cell factories and cultivation approaches to efficiently produce hyaluronan is of many interests. Here, we describe the metabolic engineering of Corynebacterium glutamicum and application of a fermentation strategy to manufacture hyaluronan with different molecular weights. C. glutamicum is engineered by combinatorial overexpression of type I hyaluronan synthase, enzymes of intermediate metabolic pathways and attenuation of extracellular polysaccharide biosynthesis. The engineered strain produces 34.2 g L−1 hyaluronan in fed-batch cultures. We find secreted hyaluronan encapsulates C. glutamicum, changes its cell morphology and inhibits metabolism. Disruption of the encapsulation with leech hyaluronidase restores metabolism and leads to hyper hyaluronan productions of 74.1 g L−1. Meanwhile, the molecular weight of hyaluronan is also highly tunable. These results demonstrate combinatorial optimization of cell factories and the extracellular environment is efficacious and likely applicable for the production of other biopolymers.